ICH-Q7 GMP Manufactured Product
Cysteamine HCl (2-MEA)
*Low Bioburden, Low Endotoxin
ANALYSIS | SPECIFICATIONS | ||
---|---|---|---|
|
White or colorless crystals or powder, may contain lumps | ||
|
Colorless, clear solution | ||
|
30.6 – 31.8% | ||
|
98.0 – 102.0% | ||
|
≤ 100 CFU/g | ||
Endotoxin |
≤ 50 EU/g |
||
|
Cystamine ≤ 2.0% |
||
|
≤ 20 mg/kg (ppm) | ||
|
Conforms to reference standard | ||
|
≤ 1.0%. | ||
|
≤ 5 ppm |
||
Purity (HPLC Area %) | ≥ 98.0% | ||
Purity (Cysteamine (HPLC)) |
≥ 92.0% |
||
|
≤ 5000 ppm |
||
Solubility | Clear and Colorless |
Printable Version
ELEMENTAL IMPURITIES: This product complies with ICHQ3D, USP <232> and USP <233> requirements for Elemental Impurities.
RESIDUAL SOLVENTS: Based on the manufacturing process and the controlled handling, storage and analysis of this product, this product complies with the requirements and specifications listed in the current USP method <467> Tables 1, 2, 3, or 4.
Bio Excipient Grade Cysteamine HCl (2-MEA), CSMH-3250 is suitable for use as an excipient. It is manufactured in accordance with the ICH-Q7 Good Manufacturing Practice Guide. This grade of Cysteamine HCl (2-MEA) is not suitable to be used as an Active Pharmaceutical Ingredient, Drug Product or Household Item.
The recommended retest period for CysteamineHCl (2- MEA) is one year from the date of manufacture.
Store in a tightly closed container, under nitrogen or argon blanket, at 2-8°C (36-46°F). Store in a dry, well- ventilated area away from incompatible substances.
10kg, 25kg and 50kg pails.
American Manufactured - FDA Registered GMP Facilities: Parenteral Excipients, GMP Small Molecule Intermediates, GMP Biological Buffers, Parenteral Carbohydrates, GMP Chlorinated Amino Acids, GMP Solutions in Sterile Single Use Packaging and other Reagent & GMP Fine Chemicals.